Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T78712 |
DNA Gyrase-IN-8
|
DNA/RNA Synthesis | Cell Cycle/Checkpoint; DNA Damage/DNA Repair |
DNA Gyrase-IN-8是一种高效的DNA gyrase抑制剂,其IC50为8.45 µM,同时展现出了抗菌活性。 | |||
T78866 |
DNA Gyrase-IN-9
|
DNA/RNA Synthesis | Cell Cycle/Checkpoint; DNA Damage/DNA Repair |
DNA Gyrase-IN-9 (compound 4j) 是一款抗细菌剂,作用于 DNA gyrase。该化合物对抑制革兰氏阳性菌的最小抑菌浓度(MIC)范围为 0.5-2 μg/mL,最小杀菌浓度(MBC)为 2-8 μg/mL。在金黄色葡萄球菌中,DNA Gyrase-IN-9 的 DNA gyrase 抑制半数有效浓度(IC50)为 6.29 μg/mL。 | |||
T62895 | DNA Gyrase-IN-4 | ||
DNA Gyrase-IN-4 (compound 8p) 是一种 DNA 促旋酶的有效抑制剂 (IC50: 0.13 μM)。DNA Gyrase-IN-4 对金黄色葡萄球菌 (MIC: 0.05 μg/ml)、单核增生李斯特菌 (MIC: 0.05 μg/ml)、沙门氏菌 (MIC: 0.05 μg/ml) 和大肠杆菌 (MIC: 8 μg/ml) 具有较好的抗菌作用。 | |||
T11289 |
Finafloxacin
|
Others | Others |
Finafloxacin, a fluoroquinolone antimicrobial agent from a new 8-cyano subclass, is most effective in slightly acidic environments (pH 5.0-6.0), a condition where other fluoroquinolones typically reduce in activity. It selectively targets bacterial type II topoisomerases, such as DNA gyrase and DNA topoisomerase IV, making it suitable for treating serious bacterial infections particularly in acidic contexts, including urinary tract infections (UTIs) and Helicobacter pylori infections. |